4//SEC Filing
KABAKOFF DAVID S 4
Accession 0001140361-23-031194
CIK 0001661059other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:31 PM ET
Size
5.1 KB
Accession
0001140361-23-031194
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
KABAKOFF DAVID S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22+14,250→ 14,250 totalExercise: $1.62Exp: 2033-06-21→ Common Stock (14,250 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024008
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:31 PM ET
- Size
- 5.1 KB